Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2021 sowie Informationen zur Geschäftsentwicklung
10:00am, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
Telefonkonferenz und Webcast sind für den 30. März 2022 um 14 Uhr MEZ geplant
BioNTech reports unbelievable YoY growth for its fiscal Q4
09:51am, Wednesday, 30'th Mar 2022
BioNTech SE shares (NASDAQ: BNTX) opened 8% up on Wednesday after the pharmaceutical company handily beat Street expectations for Q4 earnings and revenue. Notable figures in BioNTech Q4 earnings repor
Why BioNTech Shares Are Surging Today
09:20am, Wednesday, 30'th Mar 2022
BioNTech SE (NASDAQ: BNTX) reported Q4 FY21 revenues of €5.53 billion compared to €345.4 million a year ago, mainly due to high demand for the company's COVID-19 vaccine. BioNTech and its partn
Dow Jones Newswires: BioNTech reports soaring earnings, revenue on COVID vaccine, plans $1.5 billion in buybacks
06:43am, Wednesday, 30'th Mar 2022
German pharmaceutical company BioNTech SE reported soaring earnings and revenue for the fourth quarter, driven by the Covid-19 vaccine it produces with Pfizer Inc, and said it is starting a share buyb
BioNTech's Earnings Top Estimates. It Plans a Buyback and Special Dividend.
06:16am, Wednesday, 30'th Mar 2022
BioNTech says it plans to buy back up to $1.5 billion of stock over the next two years. It also will propose to pay a special dividend of €2 a share.
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
11:31pm, Tuesday, 29'th Mar 2022
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
Why Moderna and BioNTech Were Winners Today
10:07pm, Tuesday, 29'th Mar 2022 The Motley Fool
The FDA expands its authorization for both companies' coronavirus vaccines.
Why Moderna and BioNTech Were Winners Today
06:07pm, Tuesday, 29'th Mar 2022
The FDA expands its authorization for both companies' coronavirus vaccines.
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
01:22pm, Tuesday, 29'th Mar 2022
The FDA has approved a second round of the Moderna Inc (NASDAQ: MRNA) or Pfizer Inc (NYSE: PFE), and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccines for older people and certain immunocompromise
FDA authorizes fourth Covid vaccine dose for people age 50 and older
11:36am, Tuesday, 29'th Mar 2022
The U.S. Food and Drug Administration has authorized another Covid-19 vaccine dose from Pfizer and Moderna for everyone age 50 and older, as well as some immunocompromised patients. CNBC's Meg Tirrell
Earnings Previews: BioNTech, Chewy, Lululemon, Micron
10:58am, Tuesday, 29'th Mar 2022
Markets were off to a positive start on Tuesday, with the Nasdaq leading the charge with a gain of just over 1%.
Are These 2 Rivals Beating Pfizer and Moderna?
10:00am, Monday, 28'th Mar 2022 The Motley Fool
They're winning when it comes to orders.
BioNTech, Chewy, Lululemon, Walgreens, and Other Stocks to Watch
08:07am, Monday, 28'th Mar 2022
Chewy, Micron, Walgreens, Lululemon, and BioNTech release results this week. Plus, the March jobs report, February personal income and expenditures, and more economic data.
Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal
09:23am, Sunday, 27'th Mar 2022
Shanghai Nuance Pharma in-licensed China and Southeast Asia rights to a respiratory syncytial virus (RSV) vaccine from Copenhagen's Bavarian Nordic in a $225 million deal.
Why Moderna, BioNTech, and Novavax Stocks Are Tumbling Today
12:30pm, Friday, 25'th Mar 2022
Investors appear to be concerned that Uncle Sam won't foot the bill for additional COVID-19 vaccine purchases.
